Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Regenerative Medical Technology (RMTG) Non-Current Assets (2018 - 2025)

Historic Non-Current Assets for Regenerative Medical Technology (RMTG) over the last 8 years, with Q3 2025 value amounting to $3.0 million.

  • Regenerative Medical Technology's Non-Current Assets rose 3021.28% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year increase of 1384.38%. This contributed to the annual value of $2.6 million for FY2024, which is 1167.9% up from last year.
  • As of Q3 2025, Regenerative Medical Technology's Non-Current Assets stood at $3.0 million, which was up 3021.28% from $2.6 million recorded in Q2 2025.
  • In the past 5 years, Regenerative Medical Technology's Non-Current Assets ranged from a high of $6.4 million in Q2 2022 and a low of $176800.0 during Q2 2021
  • Moreover, its 5-year median value for Non-Current Assets was $2.6 million (2025), whereas its average is $3.9 million.
  • In the last 5 years, Regenerative Medical Technology's Non-Current Assets surged by 26201995.83% in 2021 and then crashed by 6667.17% in 2023.
  • Regenerative Medical Technology's Non-Current Assets (Quarter) stood at $6.3 million in 2021, then increased by 1.59% to $6.4 million in 2022, then plummeted by 63.92% to $2.3 million in 2023, then rose by 11.68% to $2.6 million in 2024, then increased by 16.95% to $3.0 million in 2025.
  • Its Non-Current Assets was $3.0 million in Q3 2025, compared to $2.6 million in Q2 2025 and $2.5 million in Q1 2025.